BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs4950928
,
EGFR
,
Fatty acid metabolic process
,
Obesity
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Fe protein
Summary
General Info
Curated Studies
Most Correlated Studies
Leukemic cells (K562) with 20uM iron (Fe-III) mesoporphyrin or mesoporphyrin alone for 20hr
Mouse erythroblasts during erythroid differentiation
Retinoic acid treatment of stellate cells - time course
PBMCs of myelopathy/tropical spastic paraparesis patients treated with Fas agonist/antagonist mAbs
Induced pluripotent stem cells, embryonic stem cells and fibroblasts in single-cell or bulk RNA-Seq
Explore Curated Studies Results
Literature
Most Relevant Literature
Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
MicroRNA-125b inhibits AML cells differentiation by directly targeting Fes.
Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis.
Selenocyanate derived Se-incorporation into the nitrogenase Fe protein cluster.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
Effects of the V1a Agonist FE 202158 in Patients With Septic Shock
The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ